New Jersey S 2647: Prohibits health care professional licensing boards from restricting or taking adverse disciplinary action for prescribing certain COVID-19 treatments.

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2022-05-16)

State: New Jersey · Session: 220 · Bill: S 2647

Subjects: DISEASE, HEALTH

Sponsors: Durr, Edward

View New Jersey S 2647 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.